InsiderSignal.AI

InsiderSignal.ai

MAIA - Maia Biotechnology, Inc.

Insider Purchase by Luput Cristian (Dir)

3 Months
After Trade
Before Trade

Loading data...

Trade Summary

2 months ago, Luput Cristian, serving as Dir at Maia Biotechnology, Inc. (MAIA), purchased 38,145 shares at $1.10 per share, for a total transaction value of $41,846.00. Following this transaction, Luput Cristian now holds 437,628 shares of MAIA.

This purchase represents a 10.00% increase in Luput Cristian's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, November 26, 2025 and publicly disclosed via SEC Form 4 filing on Monday, December 1, 2025, 5 days after the trade was made.

Maia Biotechnology, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Luput Cristian

Dir

Cristian Luput is an independent director at Maia Biotechnology, Inc. (NYSE American: MAIA), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, including its lead program THIO (ateganosine) for non-small cell lung cancer.[[3]](https://ir.maiabiotech.com/news-events/press-releases/detail/101/maia-biotechnology-announces-share-purchases-by-directors)[[4]](https://maiabiotech.com/about/board-of-directors/) He has demonstrated strong confidence in the company through multiple share purchases, including 20,000 shares on November 26, 2025, at $1.0808 each, and 18,145 shares on November 28, 2025, at an average of $1.1149, bringing his direct ownership to 437,628 shares.[[1]](https://www.investing.com/news/insider-trading-news/luput-cristian-director-at-maia-biotechnology-buys-41845-in-shares-93CH-4383280)[[2]](https://longbridge.com/en/news/268229100) Earlier, he acquired 69,282 shares in a March private placement.[[3]](https://ir.maiabiotech.com/news-events/press-releases/detail/101/maia-biotechnology-announces-share-purchases-by-directors) Mr. Luput is the founder and CEO of Optimus Realty Inc., a full-service real estate company in Chicago specializing in brokering, managing, and developing residential properties, with over 15 years of expertise.[[3]](https://ir.maiabiotech.com/news-events/press-releases/detail/101/maia-biotechnology-announces-share-purchases-by-directors)[[4]](https://maiabiotech.com/about/board-of-directors/) His career highlights include completing multiple multi-million dollar real estate partnerships, consolidations, mergers, and acquisitions.[[3]](https://ir.maiabiotech.com/news-events/press-releases/detail/101/maia-biotechnology-announces-share-purchases-by-directors)[[4]](https://maiabiotech.com/about/board-of-directors/) He serves on the boards of several charitable organizations and holds a degree in accounting and Business Administration from Babes-Bolyai University in Cluj-Napoca, Romania.[[4]](https://maiabiotech.com/about/board-of-directors/)

View full insider profile →

Trade Price

$1.10

Quantity

38,145

Total Value

$41,846.00

Shares Owned

437,628

Trade Date

Wednesday, November 26, 2025

88 days ago

SEC Filing Date

Monday, December 1, 2025

Filed 5 days after trade

HEALTHCAREBIOTECHNOLOGY

About Maia Biotechnology, Inc.

Company Overview

No company information available
View news mentioning MAIA

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/1850489

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime